Simultaneous determination of N(1)-methylnicotinamide, L-carnitine, and creatinine in human plasma and urine by liquid chromatography with mass spectrometry for assessing the activities of multiple renal cationic transporters

J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Sep 15:967:240-4. doi: 10.1016/j.jchromb.2014.07.034. Epub 2014 Aug 2.

Abstract

Organic cation transporters are responsible for the disposition of various endogenous and therapeutic agents in humans; thus, there is a great need for the development of a simple assay for simultaneous assessment of the activities of multiple transporters. Using liquid chromatography-mass spectrometry (LC/MS), we developed an assay that allows for simultaneous quantitation of plasma and urinary levels of N(1)-methylnicotinamide (a substrate of hOCT2/hMATEs), L-carnitine (a substrate of hOCTN2), and creatinine (an indicator of glomerular filtration). Samples were diluted with ultrapure water, deproteinized with trichloroacetic acid, filtered, and then injected on a cation exchange column. The analytes were separated with a gradient LC technique and detected by MS. The total assay time was less than 8 min. The lower detection limits for N(1)-methylnicotinamide, L-carnitine, and creatinine were 2, 10, and 24 ng/mL, respectively. Recovery of the analytes was almost complete. A preliminary clinical study conducted in 25 healthy subjects revealed that the mean±SD for the renal clearance (CLR) of N(1)-methylnicotinamide (272.7±81.0 mL/min) far exceeded the glomerular filtration rate (116.3±19.6 mL/min), indicating the involvement of active tubular secretion, while the mean CLR of clearance of L-carnitine was close to nil (1.5±1.4 mL/min), indicating almost complete tubular reabsorption. The present method is potentially useful for clinical studies on the genetic control of cationic transporter activities and the transporter-mediated drug interactions.

Keywords: Creatinine; Humans; LC/MS; N(1)-Methylnicotinamide; Plasma; Urine; l-carnitine.

MeSH terms

  • Carnitine / blood*
  • Carnitine / chemistry
  • Carnitine / urine*
  • Chromatography, Liquid / methods
  • Creatinine / blood*
  • Creatinine / chemistry
  • Creatinine / urine*
  • Drug Stability
  • Female
  • Humans
  • Male
  • Mass Spectrometry / methods
  • Niacinamide / analogs & derivatives*
  • Niacinamide / blood
  • Niacinamide / chemistry
  • Niacinamide / urine
  • Reproducibility of Results
  • Sensitivity and Specificity

Substances

  • Niacinamide
  • Creatinine
  • Carnitine
  • N(1)-methylnicotinamide